Authors: Egbertson, MS Bednar, B Askew, BC Bednar, RA Brashear, K Breslin, MJ Duggan, ME Fisher, TE Halczenko, W Hutchinson, JH Ihle, N Prugh, JD Wai, JS Gould, RJ Hartman, GD

Citation: Ms. Egbertson et al., Nonpeptide GPIIB/IIIA receptor antagonists. Part 21: C-6 flexibility and amide bond orientation are important factors in determining the affinity of compounds for activated or resting platelet receptors, BIOORG MED, 10(17), 2000, pp. 1943-1948

Authors: Wai, JS Egbertson, MS Payne, LS Fisher, TE Embrey, MW Tran, LO Melamed, JY Langford, HM Guare, JP Zhuang, LG Grey, VE Vacca, JP Holloway, MK Naylor-Olsen, AM Hazuda, DJ Felock, PJ Wolfe, AL Stillmock, KA Schleif, WA Gabryelski, LJ Young, SD

Citation: Js. Wai et al., 4-aryl-2,4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells, J MED CHEM, 43(26), 2000, pp. 4923-4926

Authors: Egbertson, MS Cook, JJ Bednar, B Prugh, JD Bednar, RA Gaul, SL Gould, RJ Hartman, GD Homnick, CF Holahan, MA Libby, LA Lynch, JJ Lynch, RJ Sitko, GR Stranieri, MT Vasallo, LM

Citation: Ms. Egbertson et al., Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation. (vol 42, pg 2409, 1999), J MED CHEM, 42(19), 1999, pp. 4014-4014

Authors: Egbertson, MS Cook, JJ Bednar, B Prugh, JD Bednar, RA Gaul, SL Gould, RJ Hartman, GD Homnick, CF Holahan, MA Libby, LA Lynch, JJ Lynch, RJ Sitko, GR Stranieri, MT Vassallo, LM

Citation: Ms. Egbertson et al., Non-peptide GPIIb IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation, J MED CHEM, 42(13), 1999, pp. 2409-2421